100 related articles for article (PubMed ID: 16943675)
1. Specific immunotherapy with standardized latex extract versus placebo in latex-allergic patients.
Tabar AI; Anda M; Bonifazi F; Bilò MB; Leynadier F; Fuchs T; Ring J; Galvain S; André C
Int Arch Allergy Immunol; 2006; 141(4):369-76. PubMed ID: 16943675
[TBL] [Abstract][Full Text] [Related]
2. Specific immunotherapy with a standardized latex extract versus placebo in allergic healthcare workers.
Leynadier F; Herman D; Vervloet D; Andre C
J Allergy Clin Immunol; 2000 Sep; 106(3):585-90. PubMed ID: 10984382
[TBL] [Abstract][Full Text] [Related]
3. Sublingual immunotherapy with a latex extract in paediatric patients: a double-blind, placebo-controlled study.
Bernardini R; Campodonico P; Burastero S; Azzari C; Novembre E; Pucci N; Massai C; De Martino M; Vierucci A
Curr Med Res Opin; 2006 Aug; 22(8):1515-22. PubMed ID: 16870076
[TBL] [Abstract][Full Text] [Related]
4. Double-blind, placebo-controlled study of sublingual immunotherapy in patients with latex-induced urticaria: a 12-month study.
Nettis E; Colanardi MC; Soccio AL; Marcandrea M; Pinto L; Ferrannini A; Tursi A; Vacca A
Br J Dermatol; 2007 Apr; 156(4):674-81. PubMed ID: 17493066
[TBL] [Abstract][Full Text] [Related]
5. Latex sublingual immunotherapy: can its safety be predicted?
Buyukozturk S; Gelincik A; Ozşeker F; Colakoğlu B; Dal M
Ann Allergy Asthma Immunol; 2010 Apr; 104(4):339-42. PubMed ID: 20408345
[TBL] [Abstract][Full Text] [Related]
6. Immunotherapy with mosquito (Culex quinquefasciatus) extract: a double-blind, placebo-controlled study.
Srivastava D; Singh BP; Sudha VT; Arora N; Gaur SN
Ann Allergy Asthma Immunol; 2007 Sep; 99(3):273-80. PubMed ID: 17910332
[TBL] [Abstract][Full Text] [Related]
7. Component-resolved immunologic modifications, efficacy, and tolerance of latex sublingual immunotherapy in children.
Lasa Luaces EM; Tabar Purroy AI; García Figueroa BE; Anda Apiñaniz M; Sanz Laruga ML; Raulf-Heimsoth M; Barber Hernández D
Ann Allergy Asthma Immunol; 2012 May; 108(5):367-72. PubMed ID: 22541410
[TBL] [Abstract][Full Text] [Related]
8. [Analysis of the efficacy of specific immunotherapy with house-dust mite extracts in adults with allergic rhinitis and/or asthma].
Polzehl D; Keck T; Riechelmann H
Laryngorhinootologie; 2003 Apr; 82(4):272-80. PubMed ID: 12717603
[TBL] [Abstract][Full Text] [Related]
9. Specific immunotherapy with a standardized latex extract in allergic workers: a double-blind, placebo-controlled study.
Sastre J; Fernández-Nieto M; Rico P; Martín S; Barber D; Cuesta J; de las Heras M; Quirce S
J Allergy Clin Immunol; 2003 May; 111(5):985-94. PubMed ID: 12743562
[TBL] [Abstract][Full Text] [Related]
10. Double-blind and placebo-controlled study to assess efficacy and safety of a modified allergen extract of Dermatophagoides pteronyssinus in allergic asthma.
Ameal A; Vega-Chicote JM; Fernández S; Miranda A; Carmona MJ; Rondón MC; Reina E; García-González JJ
Allergy; 2005 Sep; 60(9):1178-83. PubMed ID: 16076305
[TBL] [Abstract][Full Text] [Related]
11. Effect of one-year subcutaneous and sublingual immunotherapy on clinical and laboratory parameters in children with rhinitis and asthma: a randomized, placebo-controlled, double-blind, double-dummy study.
Yukselen A; Kendirli SG; Yilmaz M; Altintas DU; Karakoc GB
Int Arch Allergy Immunol; 2012; 157(3):288-98. PubMed ID: 22041501
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of subcutaneous immunotherapy with a biologically standardized extract of Ambrosia artemisiifolia pollen: a double-blind, placebo-controlled study.
Mirone C; Albert F; Tosi A; Mocchetti F; Mosca S; Giorgino M; Pecora S; Parmiani S; Ortolani C
Clin Exp Allergy; 2004 Sep; 34(9):1408-14. PubMed ID: 15347374
[TBL] [Abstract][Full Text] [Related]
13. Immunologic effects and tolerability profile of in-season initiation of a standardized-quality grass allergy immunotherapy tablet: a phase III, multicenter, randomized, double-blind, placebo-controlled trial in adults with grass pollen-induced rhinoconjunctivitis.
Reich K; Gessner C; Kroker A; Schwab JA; Pohl W; Villesen H; Wüstenberg E; Emminger W
Clin Ther; 2011 Jul; 33(7):828-40. PubMed ID: 21741092
[TBL] [Abstract][Full Text] [Related]
14. [Effect of 1-year specific immunotherapy with standardized house dust mite vaccine on mild to moderate allergic asthmatic patients].
Wang HY; Lin XP; Hao CL; Zhang CQ; Sun BQ; Zheng JP; Chen P; Sheng JY; Wu A; Zhong NS
Zhonghua Jie He He Hu Xi Za Zhi; 2006 Oct; 29(10):679-87. PubMed ID: 17129496
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of sublingual swallow immunotherapy in children with severe grass pollen allergic symptoms: a double-blind placebo-controlled study.
Bufe A; Ziegler-Kirbach E; Stoeckmann E; Heidemann P; Gehlhar K; Holland-Letz T; Braun W
Allergy; 2004 May; 59(5):498-504. PubMed ID: 15080830
[TBL] [Abstract][Full Text] [Related]
16. Double-blind, placebo-controlled Alternaria alternata immunotherapy: in vivo and in vitro parameters.
Lizaso MT; Tabar AI; García BE; Gómez B; Algorta J; Asturias JA; Martínez A
Pediatr Allergy Immunol; 2008 Feb; 19(1):76-81. PubMed ID: 17662037
[TBL] [Abstract][Full Text] [Related]
17. Safety and efficacy of Juniperus ashei sublingual-swallow ultra-rush pollen immunotherapy in cypress rhinoconjunctivitis. A double-blind, placebo-controlled study.
Vervloet D; Birnbaum J; Laurent P; Hugues B; Fardeau MF; Massabie-Bouchat YP; Aferiat-Derome A; André C
Int Arch Allergy Immunol; 2007; 142(3):239-46. PubMed ID: 17114889
[TBL] [Abstract][Full Text] [Related]
18. Sublingual immunotherapy for hazelnut food allergy: a randomized, double-blind, placebo-controlled study with a standardized hazelnut extract.
Enrique E; Pineda F; Malek T; Bartra J; Basagaña M; Tella R; Castelló JV; Alonso R; de Mateo JA; Cerdá-Trias T; San Miguel-Moncín Mdel M; Monzón S; García M; Palacios R; Cisteró-Bahíma A
J Allergy Clin Immunol; 2005 Nov; 116(5):1073-9. PubMed ID: 16275379
[TBL] [Abstract][Full Text] [Related]
19. Comparison of the efficacy of subcutaneous and sublingual immunotherapy in mite-sensitive patients with rhinitis and asthma--a placebo controlled study.
Mungan D; Misirligil Z; Gürbüz L
Ann Allergy Asthma Immunol; 1999 May; 82(5):485-90. PubMed ID: 10353581
[TBL] [Abstract][Full Text] [Related]
20. [Treatment perspectives: immunotherapy with latex].
Tabar AI; Anda M; Gómez B; García B; Lizaso MT; Echechipía S; Arroabarren E; Olaguibel JM
Allergol Immunopathol (Madr); 2002; 30(3):163-70. PubMed ID: 11988148
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
